253 related articles for article (PubMed ID: 11818465)
1. Positron emission tomography scanning: current and future applications.
Czernin J; Phelps ME
Annu Rev Med; 2002; 53():89-112. PubMed ID: 11818465
[TBL] [Abstract][Full Text] [Related]
2. Clinical applications of FDG-PET in oncology.
Czernin J
Acta Med Austriaca; 2002; 29(5):162-70. PubMed ID: 12506767
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography imaging in evaluation of cancer patients.
Kumar R; Bhargava P; Bozkurt MF; Zhuang H; Potenta S; Alavi A
Indian J Cancer; 2003; 40(3):87-100. PubMed ID: 14716112
[TBL] [Abstract][Full Text] [Related]
4. PET/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination.
Czernin J; Benz MR; Allen-Auerbach MS
Eur J Radiol; 2010 Mar; 73(3):470-80. PubMed ID: 20097498
[TBL] [Abstract][Full Text] [Related]
5. [Cost-effective PET scans in oncology].
Kálvin B; Fekésházy A; Lengyel Z; Szakáll S; Agoston P; Lengyel E; Székely J; Várady E; Galuska L; Trón L; Esik O
Orv Hetil; 2002 May; 143(21 Suppl 3):1255-61. PubMed ID: 12077909
[TBL] [Abstract][Full Text] [Related]
6. [Cost-effective PET investigations in oncology].
Kálvin B; Fekésházy A; Lengyel Z; Szakáll S; Agoston P; Lengyel E; Székely J; Galuska L; Trón L; Esik O
Magy Onkol; 2002; 46(3):203-23. PubMed ID: 12368917
[TBL] [Abstract][Full Text] [Related]
7. [Positron emission tomography (PET) and (F-18)-fluorodeoxyglucose in (FDG) in cancerology].
Maublant J; Vuillez JP; Talbot JN; Lumbroso J; Muratet JP; Herry JY; Artus JC
Bull Cancer; 1998 Nov; 85(11):935-50. PubMed ID: 9951421
[TBL] [Abstract][Full Text] [Related]
8. Clinical role of positron emission tomography in oncology.
Bomanji JB; Costa DC; Ell PJ
Lancet Oncol; 2001 Mar; 2(3):157-64. PubMed ID: 11902566
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000.
Reske SN; Kotzerke J
Eur J Nucl Med; 2001 Nov; 28(11):1707-23. PubMed ID: 11702115
[TBL] [Abstract][Full Text] [Related]
10. Use of positron emission tomography in oncology.
Glaspy JA; Hawkins R; Hoh CK; Phelps ME
Oncology (Williston Park); 1993 Jul; 7(7):41-6, 49-50; discussion 50-2, 55. PubMed ID: 8347460
[TBL] [Abstract][Full Text] [Related]
11. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development.
Kelloff GJ; Hoffman JM; Johnson B; Scher HI; Siegel BA; Cheng EY; Cheson BD; O'shaughnessy J; Guyton KZ; Mankoff DA; Shankar L; Larson SM; Sigman CC; Schilsky RL; Sullivan DC
Clin Cancer Res; 2005 Apr; 11(8):2785-808. PubMed ID: 15837727
[TBL] [Abstract][Full Text] [Related]
12. Clinical oncological applications of Positron Emission Tomography (PET) using fluorine-18-fluoro-2-deoxy-D-glucose.
Giorgetti A; Volterrani D; Mariani G
Radiol Med; 2002 Apr; 103(4):293-318. PubMed ID: 12107381
[TBL] [Abstract][Full Text] [Related]
13. Appropriate use of positron emission tomography with [(18)F]fluorodeoxyglucose for staging of oncology patients.
Tagliabue L; Del Sole A
Eur J Intern Med; 2014 Jan; 25(1):6-11. PubMed ID: 23910561
[TBL] [Abstract][Full Text] [Related]
14. PET scanning in lung cancer: current status and future directions.
Mac Manus MP; Hicks RJ
Semin Surg Oncol; 2003; 21(3):149-55. PubMed ID: 14508847
[TBL] [Abstract][Full Text] [Related]
15. PET/CT for the staging and follow-up of patients with malignancies.
Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
[TBL] [Abstract][Full Text] [Related]
16. 18-Fluorodeoxyglucose imaging in oncology.
Harolds JA
J Okla State Med Assoc; 1999 Sep; 92(9):457-61. PubMed ID: 10504797
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography: clinical applications in oncology. Part 1.
Kumar R; Nadig MR; Chauhan A
Expert Rev Anticancer Ther; 2005 Dec; 5(6):1079-94. PubMed ID: 16336099
[TBL] [Abstract][Full Text] [Related]
18. Recommendations on the use of 18F-FDG PET in oncology.
Fletcher JW; Djulbegovic B; Soares HP; Siegel BA; Lowe VJ; Lyman GH; Coleman RE; Wahl R; Paschold JC; Avril N; Einhorn LH; Suh WW; Samson D; Delbeke D; Gorman M; Shields AF
J Nucl Med; 2008 Mar; 49(3):480-508. PubMed ID: 18287273
[TBL] [Abstract][Full Text] [Related]
19. Clinical role of FDG PET in evaluation of cancer patients.
Kostakoglu L; Agress H; Goldsmith SJ
Radiographics; 2003; 23(2):315-40; quiz 533. PubMed ID: 12640150
[TBL] [Abstract][Full Text] [Related]
20. Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.
Delbeke D
J Nucl Med; 1999 Apr; 40(4):591-603. PubMed ID: 10210218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
